NASET News Alert

New Study Shows Melatonin Effective Sleep Aid for Children with Autism

November 01, 2017

A study published in the Journal of the American Academy of Child and Adolescent Psychiatry disclosed that children with autism spectrum disorder (ASD) who have refractory insomnia will benefit from prolonged release melatonin (PEDPRM). The trial conducted was random, placebo-controlled, and double-blind. There were 125 participants in the trial aged 2 to 17.5 years. These were patients whose insomnia continued even after behavioral intervention. Such children were administered with 2 mg of PEDPRM once daily; the dosage was increased to 5 mg or placebo for the succeeding thirteen weeks. Trial participants included children who were diagnosed by physicians of ASD regardless whether or not they had attention deficit and hyperactive disorder (ADHD) and other neurogenetic disorders. The common factor among all participants was sleep issues. Read More

Back to NASET News Alert
lost password?